General Information of the Compound
Compound ID |
CP0084605
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
Bromfenac
Show/Hide
|
||||||||||||||||||
Synonyms |
2-Amino-3-(4-bromobenzoyl)benzeneacetic acid
2-[2-amino-3-(4-bromobenzoyl)phenyl]acetic acid
AHR-10282
BROMFENAC SODIUM
Bromfenac
Bromfenac (INN)
Bromfenac [INN]
Bromfenaco
Bromfenaco [Spanish]
Bromfenacum
Bromfenacum [Latin]
Duract
Duract (TN)
Sodium 2-amino-3-(4-bromobenzoyl) phenylacetate sesquihydrate
Xibrom
Xibrom (TN)
[2-Amino-3-(4-bromo-benzoyl)-phenyl]-acetic acid
[2-amino-3-(4-bromobenzoyl)phenyl]acetic acid
{2-amino-3-[(4-bromophenyl)carbonyl]phenyl}acetic acid
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C15H12BrNO3
|
||||||||||||||||||
Molecular Weight |
334.169
|
||||||||||||||||||
Canonical SMILES |
Nc1c(CC(O)=O)cccc1C(=O)c1ccc(Br)cc1
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C15H12BrNO3/c16-11-6-4-9(5-7-11)15(20)12-3-1-2-10(14(12)17)8-13(18)19/h1-7H,8,17H2,(H,18,19)
Show/Hide
|
||||||||||||||||||
InChIKey |
ZBPLOVFIXSTCRZ-UHFFFAOYSA-N
|
||||||||||||||||||
CAS |
91714-94-2
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID | |||||||||||||||||||
DrugBank ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Clinical Information about the Compound